Skip to main content
logo
Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
0.7375
-0.0155 (-2.06%)
At close: Aug 10, 2026, 4:00 PM EDT
0.7105
-0.0270 (-3.66%)
After-hours: Aug 10, 2026, 5:03 PM EDT

Citius Oncology Financials Overview

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Dec '22
Operating Income
-43.52-23.52-20.57-12.12-0.14
Net Income
-42.51-24.76-21.15-12.70.38
Earnings Per Share
-0.47-0.34-0.31-0.190.12
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Dec '22
Cash & Investments
2.633.92000.29
Total Debt
3.83.83.800
Net Cash (Debt)
-1.170.12-3.8-00.29
Net Cash Growth
-----
Net Cash Per Share
-0.010.00-0.06-0.16

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Dec '22
Operating Cash Flow
-16.68-5.490.130-0.05
Free Cash Flow
-16.68-5.490.130-0.05
Free Cash Flow Growth
-----

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Sep '25 Sep '24 Sep '23 Dec '22 Dec '21
Forward PE
-89.00----
P/FCF Ratio
--787.14---